menu
    • menu

    Company profile for Arch Biopartners

    NEW Drugs in Dev: 5
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arch Biopartners Inc. is focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch works closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arch BiopartnersCanada Flag
    Country
    Country
    Canada
    Address
    Address
    27 St. Clair Avenue East P.O. Box 305 Toronto, Ontario, M4T 2M5 Canada
    Telephone
    Telephone
    +1 647 428 7031
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://archbiopartners.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arch-biopartners-inc-foiff-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/archbiopartners

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arch Bio Initiates Patient Recruitment For Ph II of LSALT Peptide
    Arch Bio Initiates Patient Recruitment For Ph II of LSALT Peptide

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284697/0/en/royal-columbian-hospital-begins-patient-recruitment-in-arch-biopartners-phase-ii-trial-of-lsalt-peptide-targeting-cs-aki.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Arch Biopartners Closes Non-Brokered Private Placement
    Arch Biopartners Closes Non-Brokered Private Placement

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267174/0/en/Arch-Biopartners-Closes-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Arch Biopartners Arranges Non-Brokered Private Placement
    Arch Biopartners Arranges Non-Brokered Private Placement

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264427/0/en/Arch-Biopartners-Arranges-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Arch Biopartners, Fraser Health Sign Phase II Cardiac AKI Trial
    Arch Biopartners, Fraser Health Sign Phase II Cardiac AKI Trial

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261381/0/en/Arch-Biopartners-and-the-Fraser-Health-Authority-enter-into-a-Clinical-Trial-Agreement-for-the-Phase-II-Cardiac-Surgery-Associated-AKI-Trial.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Arch Bio Begins Phase 2 CS-AKI Trial At St. Michael's Hospital
    Arch Bio Begins Phase 2 CS-AKI Trial At St. Michael's Hospital

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259672/0/en/Arch-Biopartners-Announces-St-Michael-s-Hospital-Commences-Patient-Dosing-in-the-Phase-II-CS-AKI-Trial-of-LSALT-Peptide.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share
    Arch Bio Scientists Link IL-32 To Inflammation In Diabetic
    Arch Bio Scientists Link IL-32 To Inflammation In Diabetic

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234424/0/en/Arch-Biopartners-Scientists-Publish-New-Data-Linking-the-Cytokine-IL-32-to-Inflammation-and-Diabetic-Kidney-Disease.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search